Localization of Charcot-Leyden crystal protein in individual morphological phenotypes of human basophils stimulated by f-Met peptide

Clinical and Experimental Allergy

Volumn 27, Issue 4, 1997, Pages 452-474

  Dvorak, A M ^a   Macglashan, D W ^b   Warner, J A ^c   Letourneau, L ^a   Morgan, E S ^a   Lichtenstein, L M ^b   Ackerman, S J ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anaphylactic degranulation; Galectin; Lysophospholipase; Piecemeal degranulation; Secretion; Vesicular transport

Indexed keywords

CHARCOT LEYDEN CRYSTAL PROTEIN; FORMYLPEPTIDE; GALECTIN; LYSOPHOSPHOLIPASE; UNCLASSIFIED DRUG;

ADULT; ANAPHYLAXIS; ARTICLE; BASOPHIL; CELL GRANULE; DEGRANULATION; ENDOCYTOSIS; HISTAMINE RELEASE; HUMAN; HUMAN CELL; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; ULTRASTRUCTURE;

EID: 0030967140     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1997.tb00732.x     Document Type: Article

References (52)

1. Dvorak AM. Morphologic and immunologic characterization of human basophils, 1879 to 1985. Riv Immunol Immunofarmacol 1988; 8:50-83.
2. Dvorak HF, Dvorak AM. Basophilic leucocytes: structure, function and role in disease. In: Lichtman MA, ed. Granulocyte and monocyte abnormalities, Vol. 4 (#3) in the series Clinics in Haematology. London: W.B. Saunders, 1975:651-83.
3. Hastie R. A study of the ultrastructure of human basophil leukocytes. Lab Invest 1974; 31:223-31.
4. Dvorak AM, Warner JA, Kissell S, Lichtenstein LM, MacGlashan DW, Jr. F-Met peptide-induced degranulation of human basophils. Lab Invest 1991; 64:234-53.
5. Dvorak AM, Newball HH, Dvorak HF, Lichtenstein LM. Antigen-induced IgE-mediated degranulation of human basophils. Lab Invest 1980; 43:126-39.
6. Dvorak AM, Mihm MC, Jr, Dvorak HF. Degranulation of basophilic leukocytes in allergic contact dermatitis reactions in man. J Immunol 1976; 116:687-95.
7. Dvorak AM, Dvorak HF, Karnovsky MJ. Uptake of horseradish peroxidase by guinea pig basophilic leukocytes. Lab Invest 1972; 26:27-39.
8. Dvorak AM, Hammond ME, Morgan E et al. Evidence for a vesicular transport mechanism in guinea pig basophilic leukocytes. Lab Invest 1980; 42:263-76.
9. Dvorak AM, Klebanoff SJ, Henderson WR et al. Vesicular uptake of eosinophil peroxidase by guinea pig basophils and by cloned mouse mast cells and granule-containing lymphoid cells. Am J Pathol 1985; 118:425-38.
10. Dvorak AM, Ishizaka T, Galli SJ. Ultrastructure of human basophils developing in vitro. Evidence for the acquisition of peroxidase by basophils and for different effects of human and murine growth factors on human basophil and eosinophil maturation. Lab Invest 1985; 53:57-71.
11. Ackerman SJ, Durack DT, Gleich GJ. Eosinophil effector mechanisms in health and disease. In: Gallin JI, Fauci AS, eds. Advances in host defense mechanisms, Vol. 1. New York: Raven Press, 1982:269-93.
12. Charcot JM, Robin C. Observation de leucocythémie. Mem Soc Biol (Paris) 1853; 5:44.
13. Dvorak AM, Ackerman SJ, Weller PF. Subcellular morphology and biochemistry of eosinophils. In: Harris JR, ed. Megakaryocytes, platelets, macrophages and eosinophils, Vol. 2 in the series Blood Cell Biochemistry, Harris JR, series ed. London: Plenum, 1991:237-344.
14. Leyden E. Zur Kenntniss des Bronchial-Asthma. Arch Pathol Anat 1872; 54:324-52.
15. Ackerman SJ, Weil GJ, Gleich GJ. Formation of CharcotLeyden crystals by human basophils. J Exp Med 1982; 155:1597-609.
16. Archer GT, Blackwood A. Formation of Charcot-Leyden crystals in human eosinophils and basophils and study of the composition of isolated crystals. J Exp Med 1965; 122:173-80.
17. Dvorak AM, Ackerman SJ. Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to granules and intragranular crystals in mature human basophils. Lab Invest 1989; 60:557-67.
18. Ackerman SJ, Corrette SE, Rosenberg HF et al. Molecular cloning and characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase): similarities to IgE-binding proteins and the S-type animal lectin superfamily. J Immunol 1993; 150:456-68.
19. Ackerman SJ, Loegering DA, Gleich GJ. The human eosinophil Charcot-Leyden crystal protein: biochemical characteristics and measurement by radioimmunoassay. J Immunol 1980; 125:2118-26.
20. Gleich GJ, Loegering DA, Mann KG, Maldonado JE. Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils. J Clin Invest 1976; 57:633-40.
21. Weller PF, Bach D, Austen KF. Human eosinophil lysophospholipase: the sole protein component of Charcot-Leyden crystals. J Immunol 1982; 128:1346-9.
22. Weller PF, Bach DS, Austen KF. Biochemical characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). J Biol Chem 1984; 259:15100-5.
23. Zhou Z-Q, Tenen DG, Dvorak AM, Ackerman SJ. The gene for human eosinophil Charcot-Leyden crystal protein directs expression of lysophospholipase activity and spontaneous crystallization in transiently transfected COS cells. J Leukocyte Biol 1992; 52:588-95.
24. Dvorak AM, Furitsu T, Letourneau L, Ishizaka T, Ackerman SJ. Mature eosinophils stimulated to develop in human cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5.1. Piecemeal degranulation of specific granules and distribution of Charcot-Leyden crystal protein. Am J Pathol 1991; 138:69-82.
25. Dvorak AM, Letourneau L, Login GR, Weller PF, Ackerman SJ. Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to a distinct crystalloid-free granule population in mature human eosinophils. Blood 1988; 72:150-8.
26. Dvorak AM, Letourneau L, Weller PF, Ackerman SJ. Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) to intracytoplasmic crystals in tumor cells of primary solid and papillary neoplasm of the pancreas. Lab Invest 1990; 62:608-15.
27. Dvorak AM, Weller PF, Monahan-Earley RA, Letourneau L, Ackerman SJ. Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) and peroxidase in macrophages, eosinophils and extracellular matrix of the skin in the hypereosinophilic syndrome. Lab Invest 1990; 62:590-607.
28. Warner JA, Peters SP, Lichtenstein LM et al. Differential release of mediators from human basophils: differences in arachidonic acid metabolism following activation by unrelated stimuli. J Leukocyte Biol 1989; 45:558-71.
29. Warner JA, Reshef A, MacGlashan DW, Jr. A rapid Percoll technique for the purification of human basophils. J Immunol Methods 1987; 105:107-10.
30. de Boer M, Roos D. Metabolic comparison between basophils and other leukocytes from human blood. J Immunol 1986; 136:3447-54.
31. Siraganian RP. An automated continuous-flow system for the extraction and fluorometric analysis of histamine. Anal Biochem 1974; 57:383-94.
32. Dvorak AM, Ishizaka T, Letourneau L et al. Charcot-Leyden crystal protein distribution in basophils and its absence in mast cells that differentiate from human umbilical cord blood precursor cells cultured in murine fibroblast culture supernatants or in recombinant human c-kit ligand. J Histochem Cytochem 1994; 42:251-63.
33. Hook WA, Schiffmann E, Aswanikumar S, Siraganian RP. Histamine release by chemotactic, formyl methionine-containing peptides. J Immunol 1976; 117:594-6.
34. Siraganian RP, Hook WA. Mechanism of histamine release by formyl methionine-containing peptides. J Immunol 1977; 119:2078-83.
35. Findlay SR, Dvorak AM, Kagey-Sobotka A, Lichtenstein LM. Hyperosmolar triggering of histamine release from human basophils. J Clin Invest 1981; 67:1604-13.
36. Dvorak AM, Galli SJ, Morgan E et al. Anaphylactic degranulation of guinea pig basophilic leukocytes. I. Fusion of granule membranes and cytoplasmic vesicles: formation and resolution of degranulation sacs. Lab Invest 1981; 44:174-91.
37. Golightly LM, Thomas LL, Dvorak AM, Ackerman SJ. Charcot-Leyden crystal protein in the degranulation and recovery of activated basophils. J Leukocyte Biol 1992; 51:386-92.
38. Akey CW, Goldfarb DS. Protein import through the nuclear pore complex is a multistep process. J Cell Biol 1989; 109:971-82.
39. Borer RA, Lehner CF, Eppenberger HM, Nigg EA. Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 1989; 56:379-90.
40. Dingwall C. The accumulation of proteins in the nucleus. Trends Biochem Sci 1985; 10:64-6.
41. Dworetzky SI, Feldherr CM. Translocation of RNA-coated gold particles through the nuclear pores of oöcytes. J Cell Biol 1988; 106:575-84.
42. Dworetzky SI, Lanford RE, Feldherr CM. The effects of variations in the number and sequence of targeting signals on nuclear uptake. J Cell Biol 1988; 107:1279-87.
43. Featherstone C, Darby MK, Gerace L. A monoclonal antibody against the nuclear pore complex inhibits nucleocytoplasmic transport of protein and RNA in vivo. J Cell Biol 1988; 107:1289-97.
44. Newmeyer DD, Forbes DJ. Nuclear import can be separated into distinct steps in vitro: nuclear pore binding and translocation. Cell 1988; 52:641-53.
45. Paine PL, Moore LC, Horowitz SB. Nuclear envelope permeability. Nature 1975; 254:109-14.
46. Richardson WD, Mills AD, Dilworth SM, Laskey RA, Dingwall C. Nuclear protein migration involves two steps: rapid binding at the nuclear envelope followed by slower translocation through nuclear pores. Cell 1988; 52:655-64.
47. Schindler M, Jiang LW. Epidermal growth factor and insulin stimulate nuclear pore-mediated macromolecular transport in isolated rat liver nuclei. J Cell Biol 1987; 104:849-53.
48. Yoneda Y, Imamoto-Sonobe N, Matsuoka Y et al. Antibodies to Asp-Asp-Glu-Asp can inhibit transport of nuclear proteins into the nucleus. Science 1988; 242:275-8.
49. Zimmer FJ, Dreyer C, Hausen P. The function of the nuclear envelope in nuclear protein accumulation. J Cell Biol 1988; 106:1435-44.
50. Görlich D, Mattaj IW. Nucleocytoplasmic transport. Science 1996; 271:1513-8.
51. Leonidas DD, Elbert BL, Zhou Z et al. Crystal structure of human Charcot-Leyden crystal protein, an eosinophil lysophospholipase, identifies it as a new member of the carbohydrate-binding family of galectins. Structure 1995; 3:1379-93.
52. Dagher SF, Wang JL, Patterson RJ. Identification of galectin-3 as a factor in pre-mRNA splicing. Proc Natl Acad Sci USA 1995; 92:1213-7.